Filella X - Search Results

1

miRNAs as novel biomarkers in the management of prostate cancer.

Filella X, Foj L. Filella X, et al. Clin Chem Lab Med. 2017 May 1;55(5):715-736. doi: 10.1515/cclm-2015-1073. Clin Chem Lab Med. 2017. PMID: 26751899 Free article. Review.

2

Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.

Filella X, Molina R, Jo J, Umbert B, Bedini JL, Ballesta AM. Filella X, et al. Tumour Biol. 1990;11(6):289-94. doi: 10.1159/000217664. Tumour Biol. 1990. PMID: 1700860

3

Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases.

Molina R, Filella X, Bruix J, Mengual P, Bosch J, Calvet X, Jo J, Ballesta AM. Molina R, et al. Among authors: filella x. Clin Chem. 1991 Aug;37(8):1379-83. Clin Chem. 1991. PMID: 1868598

4

Value of PSA (prostate-specific antigen) in the detection of prostate cancer in patients with urological symptoms. Results of a multicentre study.

Filella X, Molina R, Ballesta AM, Gil MJ, Allepuz C, Rioja LA. Filella X, et al. Eur J Cancer. 1996 Jun;32A(7):1125-8. doi: 10.1016/0959-8049(96)00092-5. Eur J Cancer. 1996. PMID: 8758241 Clinical Trial.

5

Free and total PSA in the diagnosis of prostate cancer.

Filella X, Alcover J, Molina R, Rodríguez A, Carretero P, Ballesta AM. Filella X, et al. Tumour Biol. 1997;18(6):332-40. doi: 10.1159/000218047. Tumour Biol. 1997. PMID: 9372866

6

Active surveillance in prostate cancer: the need to standardize.

Filella X, Alcover J, Molina R. Filella X, et al. Tumour Biol. 2011 Oct;32(5):839-43. doi: 10.1007/s13277-011-0193-2. Epub 2011 May 28. Tumour Biol. 2011. PMID: 21625940 Review.

7

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases.

Molina R, Escudero JM, Augé JM, Filella X, Foj L, Torné A, Lejarcegui J, Pahisa J. Molina R, et al. Among authors: filella x. Tumour Biol. 2011 Dec;32(6):1087-95. doi: 10.1007/s13277-011-0204-3. Epub 2011 Aug 24. Tumour Biol. 2011. PMID: 21863264 Free PMC article.

8

Increased plasma concentrations of tumour markers in the absence of neoplasia.

Trapé J, Filella X, Alsina-Donadeu M, Juan-Pereira L, Bosch-Ferrer Á, Rigo-Bonnin R; Oncology Section of the Catalan Association of Clinical Laboratory Science. Trapé J, et al. Among authors: filella x. Clin Chem Lab Med. 2011 Oct;49(10):1605-20. doi: 10.1515/CCLM.2011.694. Epub 2011 Sep 6. Clin Chem Lab Med. 2011. PMID: 21892908 Review.

9

Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.

Escudero JM, Auge JM, Filella X, Torne A, Pahisa J, Molina R. Escudero JM, et al. Among authors: filella x. Clin Chem. 2011 Nov;57(11):1534-44. doi: 10.1373/clinchem.2010.157073. Epub 2011 Sep 20. Clin Chem. 2011. PMID: 21933899

10

Circulating levels of HER-2/neu oncoprotein in breast cancer.

Molina R, Escudero JM, Muñoz M, Augé JM, Filella X. Molina R, et al. Among authors: filella x. Clin Chem Lab Med. 2012 Jan 4;50(1):5-21. doi: 10.1515/cclm.2011.822. Clin Chem Lab Med. 2012. PMID: 22505536 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page